The text states that Europe fears medicine shortages due to the war against Iran. The UK imports about 75% of medicines, with reserves for only weeks or days. In Germany, while large-scale shortages aren't present, there are concerns. Many medications depend on raw materials from the region, and the shortage of helium could delay production. Rising transportation and material costs also affect the industry.

Infact verdict: Mixed (42/100).

The analysis of the claims based on the evidence results in varying factual accuracies and confidence levels for each assertion. The UK's import rate for medicines does not reach 75% based on the provided data. UK drug reserves' duration cannot be directly confirmed or refuted with the current evidence, as the focus appears to be more general. The influence of the Strait of Hormuz on pharmaceutical transport mainly affects the U.S. rather than directly confirming a significant percentage of supplies passing through it. Helium shortages are noted, but their direct impact on German pharmaceutical production was not corroborated here. Therefore, each claim has been evaluated accordingly based on available evidence and reliability.